Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2022)
Corcept Therapeutics (CORT) posted Interest & Investment Income of -$1.0 million for Q1 2022, down 4330.43% sequentially from -$23000.0 in Q3 2021, and down 430.73% YoY from $308107.1 in Q1 2021.
Powered by 
Analysis
Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2022) Analysis & Trends
Corcept Therapeutics has reported Interest & Investment Income for 8 years, with the latest figure at -$1.0 million in Q1 2022.
- Quarterly Interest & Investment Income fell 430.73% year-over-year to -$1.0 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was -$1.3 million (down 2016.42% YoY) and the FY2019 annual result came in at $327000.0, up 6440.0% from the prior year.
- Interest & Investment Income retreated to -$1.0 million in Q1 2022 per CORT's latest filing, from -$23000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $545000.0 in Q2 2020 and troughed at -$1.0 million in Q1 2022.
- A 5-year average of -$46200.0 and a median of -$2000.0 in 2019 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2018 and 2020: Interest & Investment Income soared 1566.67% in 2018, then sank 17250.0% in 2020.
- Over 5 years, Interest & Investment Income stood at $82000.0 in 2018, then slumped by 175.61% to -$62000.0 in 2019, then tumbled by 459.68% to -$347000.0 in 2020, then soared by 93.37% to -$23000.0 in 2021, then sank by 4330.43% to -$1.0 million in 2022.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$1.0 million, -$23000.0, and -$50000.0 for Q1 2022, Q3 2021, and Q2 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -1.02 Mn |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -50,000.00 |
| Mar 31, 2021 | -192,000.00 |
| Sep 30, 2020 | -347,000.00 |
| Jun 30, 2020 | 545,000.00 |
| Mar 31, 2020 | 61,000.00 |
| Dec 31, 2019 | -62,000.00 |
| Sep 30, 2019 | -2,000.00 |
| Jun 30, 2019 | 227,000.00 |
| Mar 31, 2019 | 164,000.00 |
| Dec 31, 2018 | 82,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Jun 30, 2018 | 25,000.00 |
| Mar 31, 2018 | -152,000.00 |
| Dec 31, 2017 | -61,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | -5,000.00 |
| Mar 31, 2017 | -12,000.00 |
| Sep 30, 2011 | 3,000.00 |